Optiver Holding B.V. Cytokinetics Inc Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Cytokinetics Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 855 shares of CYTK stock, worth $56,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
855
Previous 1,066
19.79%
Holding current value
$56,806
Previous $35,000
31.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
446Shares Held
129MCall Options Held
5.25MPut Options Held
1.18M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$492 Million0.07% of portfolio
-
State Street Corp Boston, MA5.62MShares$373 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...